drugset / Trial / NCT00124475

Efficacy and Safety of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis

NCT00124475

Phase 3 Completed 1035 enrolled Basilea Pharmaceutica
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to determine the therapeutic effect of alitretinoin, a retinoid, on severe, therapy refractory chronic hand dermatitis.

Timeline

Start
2004-12
Primary completion
2006-10
Completion
2007-09

Drugs

EvaluationDrugModalityDoseRoute
Subject alitretinoin Other / unclassified

Indications